A number of other polymorphisms in CFH [144], as well as in other genes involved in the alternative complement cascade, have also been demonstrated to affect AMD risk, including genes for complement component 2 (C2), complement component 3 (C3), and complement factor I (CFI) [29, 144–147]. The gene discussed is C3; the disease is age-related macular degeneration.